Abiopharma

Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy

Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder

Indivior Provides Full-Year 2026 Financial Guidance and Business Update

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases

NervGen Pharma Begins Trading on Nasdaq Today

Teleflex - Teleflex Announces Leadership Transition

Teleflex Announces Leadership Transition

Grifols Communication - Laura de la Cruz appointed as the new Secretary non-member of the Board of Directors

Aclarion Provides 2025 Update and 2026 Corporate Outlook

Pathenbot, a Subsidiary of CN Energy (NASDAQ: CNEY), Receives LeaderXport × BossHub Innovation Award at CES 2026